The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro
- 1 August 2002
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 83 (8) , 1993-2000
- https://doi.org/10.1099/0022-1317-83-8-1993
Abstract
The Towne strain of human cytomegalovirus (HCMV), originally recovered from the urine of a congenitally infected newborn, was attenuated through 125 passages in human embryonic lung fibroblast cell cultures. Although reliable markers of attenuation were not identified, the virus was shown to be attenuated by inoculation of both healthy human volunteers and immunocompromised patients. More recently, Towne (like other laboratory-adapted strains) was shown not to have two biological properties typical of recent clinical isolates: endothelial cell tropism and polymorphonuclear leukocyte tropism. These markers of attenuation are lost by all clinical isolates on extensive propagation in cell cultures and are apparently associated with one another. Here, we show that Towne may reacquire both endothelial cell tropism and leuko- (polymorphonuclear- and monocyte-) tropism on adaptation to growth in endothelial cell cultures. However, reversion to endothelial cell tropism is dissociated from reversion to leukotropism, since the latter was reacquired 10–20 passages later. Thus, these two biological properties, which were considered to be encoded by the same viral gene(s), appear to be distinct. Both restriction fragment length polymorphism and Southern blot analysis demonstrated the identity of the attenuated and endothelial cell tropic variants of Towne, thus suggesting that only minor variations (mutations) of the viral genome may be responsible for loss or reacquisition of the two biological properties. Viral genes involved in endothelial cell tropism and leukotropism remain to be identified. However, reversion of attenuated strains to pathogenicity in vivo cannot be excluded a priori.Keywords
This publication has 33 references indexed in Scilit:
- Human Cytomegalovirus and Human Umbilical Vein Endothelial Cells: Restriction of Primary Isolation to Blood Samples and Susceptibilities of Clinical Isolates from Other Sources to AdaptationJournal of Clinical Microbiology, 2002
- Reactivation of Latent Human Cytomegalovirus in CD14+Monocytes Is Differentiation DependentJournal of Virology, 2001
- In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cellsJournal of General Virology, 2001
- Human Cytomegalovirus Replicates Abortively in Polymorphonuclear Leukocytes after Transfer from Infected Endothelial Cells via Transient Microfusion EventsJournal of Virology, 2000
- In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.Journal of Clinical Investigation, 1998
- HUMAN CYTOMEGALOVIRUS (HCMV) LEUKODNAEMIA CORRELATES MORE CLOSELY WITH CLINICAL SYMPTOMS THAN ANTIGENEMIA AND VIREMIA IN HEART AND HEART-LUNG TRANSPLANT RECIPIENTS WITH PRIMARY HCMV INFECTION1Transplantation, 1998
- Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cellsJournal of General Virology, 1991
- Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a ChallengeThe Journal of Infectious Diseases, 1989
- Comparative Virulence and Immunogenicity of the Towne Strain and a Nonattenuated Strain of CytomegalovirusAnnals of Internal Medicine, 1984
- Clinical Trials of Immunization with the Towne 125 Strain of Human CytomegalovirusThe Journal of Infectious Diseases, 1976